X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (739) 739
animals (411) 411
aminophenols - pharmacology (344) 344
humans (321) 321
male (252) 252
rats (208) 208
pharmacology & pharmacy (186) 186
toxicology (119) 119
mice (115) 115
aminophenols - chemistry (112) 112
aminophenols - metabolism (107) 107
female (99) 99
cystic fibrosis - drug therapy (98) 98
biochemistry & molecular biology (97) 97
aminophenols (96) 96
quinolones - pharmacology (96) 96
cystic fibrosis (95) 95
cystic fibrosis transmembrane conductance regulator - genetics (90) 90
aminophenol (86) 86
mutation (83) 83
aminophenols - therapeutic use (82) 82
chemistry, medicinal (79) 79
cystic fibrosis - genetics (76) 76
p-aminophenol (75) 75
acetaminophen (71) 71
dose-response relationship, drug (70) 70
aminophenols - toxicity (69) 69
maleimides - pharmacology (68) 68
in vitro techniques (66) 66
in-vitro (62) 62
cells, cultured (61) 61
molecular structure (61) 61
para-aminophenol (59) 59
quinolones - therapeutic use (59) 59
kinetics (58) 58
toxicity (58) 58
structure-activity relationship (55) 55
ivacaftor (54) 54
oxidation-reduction (54) 54
analysis (50) 50
rats, sprague-dawley (50) 50
cystic fibrosis transmembrane conductance regulator - metabolism (49) 49
nephrotoxicity (49) 49
metabolism (47) 47
chemistry, multidisciplinary (46) 46
respiratory system (46) 46
biotransformation (45) 45
glycogen synthase kinase 3 - antagonists & inhibitors (45) 45
proteins (45) 45
adult (44) 44
article (44) 44
chemistry (44) 44
aminophenols - chemical synthesis (43) 43
kidney - drug effects (43) 43
liver - drug effects (43) 43
enzyme inhibitors - pharmacology (41) 41
paracetamol (41) 41
apoptosis (40) 40
cell line (40) 40
glutathione - metabolism (40) 40
oxidation (39) 39
phosphorylation (38) 38
time factors (38) 38
anti-bacterial agents - pharmacology (37) 37
glycogen synthase kinase 3 - metabolism (37) 37
pharmacology (37) 37
rats, inbred f344 (37) 37
cell line, tumor (34) 34
chemistry, organic (34) 34
cystic fibrosis - physiopathology (33) 33
liver - metabolism (33) 33
glycogen synthase kinase 3 beta (32) 32
old medline (32) 32
rats, inbred strains (32) 32
acetaminophen - metabolism (31) 31
antineoplastic agents - pharmacology (31) 31
liver (31) 31
metabolites (31) 31
oxidative stress (31) 31
derivatives (30) 30
cftr potentiator (29) 29
glutathione (29) 29
transmembrane conductance regulator (29) 29
abridged index medicus (28) 28
activation (28) 28
aminophenols - pharmacokinetics (28) 28
cell survival - drug effects (28) 28
cystic fibrosis - metabolism (28) 28
cystic-fibrosis (28) 28
inhibition (28) 28
mice, inbred c57bl (28) 28
aminophenols - administration & dosage (27) 27
aminopyridines - pharmacology (27) 27
aniline compounds - metabolism (27) 27
apoptosis - drug effects (27) 27
benzodioxoles - pharmacology (27) 27
cancer (27) 27
cell biology (27) 27
dogs (27) 27
expression (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (833) 833
Japanese (11) 11
Chinese (6) 6
German (6) 6
Russian (6) 6
French (5) 5
Dutch (3) 3
Italian (2) 2
Polish (2) 2
Croatian (1) 1
Serbian (1) 1
Slovak (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation Research: Journal of the American Heart Association, ISSN 0009-7330, 04/2004, Volume 94, Issue 7, pp. 960 - 966
ABSTRACT—Glycogen synthase kinase (GSK) inhibition produced by ischemic preconditioning has been previously shown to be regulated through... 
Phosphatidylinositol-3 kinase | Reperfusion | Glycogen synthase kinase | Target of rapamycin | Opioids | LOCALIZATION | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PROTECTION | PHOSPHORYLATION | phosphatidylinositol-3 kinase | PHOSPHATIDYLINOSITOL 3-KINASE | CELL-SURVIVAL | KINASE-3-BETA | INSULIN | P70S6 KINASE | INDUCED DELAYED CARDIOPROTECTION | glycogen synthase kinase | PERIPHERAL VASCULAR DISEASE | target of rapamycin | HEMATOLOGY | reperfusion | opioids | Glycogen Synthase Kinase 3 - physiology | Maleimides - pharmacology | Receptors, Retinoic Acid - physiology | Glycogen Synthase Kinase 3 beta | Male | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Receptors, Thyroid Hormone - antagonists & inhibitors | Aminophenols - pharmacology | Cardiotonic Agents - therapeutic use | Myocardial Infarction - pathology | Indoles - pharmacology | Benzamides - pharmacology | Chromones - pharmacology | Nuclear Receptor Subfamily 1, Group F, Member 3 | Morphine - pharmacology | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Morpholines - pharmacology | Rats | Receptors, Retinoic Acid - antagonists & inhibitors | Cardiotonic Agents - pharmacology | Myocardial Infarction - metabolism | Receptors, Opioid, delta - drug effects | Piperazines - pharmacology | Rats, Sprague-Dawley | Receptors, Thyroid Hormone - physiology | Sirolimus - pharmacology | Animals | Androstadienes - pharmacology | Signal Transduction - drug effects | Narcotic Antagonists - pharmacology | Phosphatidylinositol 3-Kinases - physiology | Premedication | Index Medicus
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 05/2015, Volume 754, pp. 32 - 40
Journal Article
Biology of Reproduction, ISSN 0006-3363, 2013, Volume 89, Issue 2, pp. 43 - 43
We have previously shown that fatty acid oxidation (FAO) is required for AMP-activated protein kinase (PRKA)-induced maturation in vitro. In the present study,... 
Fatty acid oxidation | AMPK | Meiotic resumption | PRKA | Oocyte maturation | BETA-OXIDATION | VITRO | ACTIVATED PROTEIN-KINASE | MURINE OOCYTES | meiotic resumption | DEVELOPMENTAL COMPETENCE | EARLY EMBRYO DEVELOPMENT | REPRODUCTIVE BIOLOGY | EPIDERMAL-GROWTH-FACTOR | fatty acid oxidation | oocyte maturation | ENERGY-METABOLISM | POTENTIAL ROLE | CARNITINE PALMITOYLTRANSFERASE-I | Meiosis - physiology | AMP-Activated Protein Kinases - metabolism | Amphiregulin | Glycoproteins - pharmacology | Aminophenols - pharmacology | Aminoimidazole Carboxamide - pharmacology | Follicle Stimulating Hormone - pharmacology | Ribonucleotides - pharmacology | Meiosis - drug effects | Ovarian Follicle - drug effects | Cumulus Cells - drug effects | Epoxy Compounds - pharmacology | EGF Family of Proteins | Cumulus Cells - metabolism | Ovarian Follicle - physiology | Oocytes - drug effects | Female | Acyl Coenzyme A - metabolism | Fatty Acids - metabolism | Ovarian Follicle - metabolism | Cumulus Cells - physiology | Oxidation-Reduction | Malonyl Coenzyme A - pharmacology | Oocytes - metabolism | Hydrazones - pharmacology | Animals | Oocytes - physiology | Aminoimidazole Carboxamide - analogs & derivatives | Thioglycolates - pharmacology | Intercellular Signaling Peptides and Proteins - pharmacology | Mice | Epidermal Growth Factor - pharmacology | Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2017, Volume 377, Issue 21, pp. 2024 - 2035
Approximately 5% of patients with cystic fibrosis express one allele with some retained CFTR function. In a prospective trial, tezacaftor–ivacaftor had a... 
POPULATION | REGULATOR | MEDICINE, GENERAL & INTERNAL | LUMACAFTOR | EFFICACY | SAFETY | PHENOTYPE | AGED 6-11 YEARS | RANDOMIZED CONTROLLED-TRIAL | F508DEL-CFTR | G551D-CFTR MUTATION | Forced Expiratory Volume - drug effects | Cystic Fibrosis - physiopathology | Humans | Male | Aminophenols - therapeutic use | Quinolones - pharmacology | Aminophenols - adverse effects | Aminophenols - pharmacology | Young Adult | Quinolones - adverse effects | Quinolones - therapeutic use | Cystic Fibrosis Transmembrane Conductance Regulator - pharmacology | Adult | Benzodioxoles - adverse effects | Female | Indoles - pharmacology | Benzodioxoles - therapeutic use | Child | Double-Blind Method | Cross-Over Studies | Cystic Fibrosis Transmembrane Conductance Regulator - therapeutic use | Indoles - adverse effects | Cystic Fibrosis - genetics | Cystic Fibrosis Transmembrane Conductance Regulator - adverse effects | Adolescent | Quality of Life | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Heterozygote | Indoles - therapeutic use | Mutation | Benzodioxoles - pharmacology | Cystic Fibrosis - drug therapy | Drug Combinations | Proteins | Clonal deletion | Clinical trials | Heterozygotes | Cystic fibrosis | Cystic fibrosis transmembrane conductance regulator | Gene deletion | Drug therapy | Patients | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Oxidative Medicine and Cellular Longevity, ISSN 1942-0900, 2017, Volume 2017, pp. 6792543 - 10
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 09/2017, Volume 50, Issue 3, pp. 427 - 435
Journal Article
Neurogastroenterology & Motility, ISSN 1350-1925, 06/2015, Volume 27, Issue 6, pp. 875 - 884
Journal Article
Cell Host & Microbe, ISSN 1931-3128, 11/2012, Volume 12, Issue 5, pp. 645 - 656
Typhimurium specifically targets antigen-sampling microfold (M) cells to translocate across the gut epithelium. Although M cells represent a small proportion... 
CANCER CELLS | TRANSCRIPTION | MICROBIOLOGY | MESENCHYMAL TRANSITION | BETA-CATENIN | VIROLOGY | MOUSE PEYERS-PATCHES | DISEASE | NF-KAPPA-B | OSTEOCLAST DIFFERENTIATION | EXPRESSION | PARASITOLOGY | SNAIL | Transcription Factor RelB - biosynthesis | Intestinal Mucosa - metabolism | Epithelial Cells - metabolism | RANK Ligand - metabolism | Enterocytes - metabolism | Humans | Maleimides - pharmacology | Glycogen Synthase Kinase 3 beta | NF-kappa B - metabolism | Salmonella Infections - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Wnt Proteins - metabolism | Aminophenols - pharmacology | Salmonella typhimurium - metabolism | Quinoxalines - pharmacology | Epithelial-Mesenchymal Transition | Cell Transdifferentiation | Female | Cell Differentiation | Receptor Activator of Nuclear Factor-kappa B - metabolism | Chromones - pharmacology | Epithelial Cells - cytology | Snail Family Transcription Factors | Wnt Signaling Pathway | NF-kappa B - antagonists & inhibitors | Salmonella typhimurium - pathogenicity | Vimentin - biosynthesis | Enterocytes - cytology | Glycogen Synthase Kinase 3 - antagonists & inhibitors | Mice, Inbred C57BL | Cells, Cultured | Morpholines - pharmacology | Transcription Factors - antagonists & inhibitors | Transcription Factors - biosynthesis | Intestinal Mucosa - microbiology | Glycogen Synthase Kinase 3 - metabolism | beta Catenin - metabolism | Peptides - pharmacology | Transcription Factors - metabolism | Animals | Transcription Factor RelB - metabolism | RANK Ligand - antagonists & inhibitors | Epithelial Cells - microbiology | Bacterial Proteins - metabolism | Mice | Benzylamines - pharmacology | Vimentin - antagonists & inhibitors | Salmonella | Analysis | Universities and colleges | Index Medicus
Journal Article
Journal Article
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 08/2016, Volume 311, Issue 2, pp. L192 - L207
Journal Article